Sarcopenic diabetes is an under-recognized and unmet clinical priority. A call for action from the European Society for Clinical Nutrition and Metabolism and the Diabetes Nutrition Study Group
Authors:
- Rocco BarazzoniRBRocco Barazzoni
- John L. SievenpiperJSJohn L. Sievenpiper
Open Access
- 25 October 2025
- journal article
- Published by Elsevier in Clinical Nutrition
- Vol. 55, 208-218
Abstract
No abstract availableKeywords
This publication has 132 references indexed in Scilit:
- An Energy-Reduced Mediterranean Diet, Physical Activity, and Body CompositionJAMA Network Open, 2023
- Evidence-based European recommendations for the dietary management of diabetesDiabetologia, 2023
- Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetologia, 2022
- Nordic dietary patterns and cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies and randomised controlled trialsDiabetologia, 2022
- Pathogenesis of sarcopenia and the relationship with fat mass: descriptive reviewJournal of Cachexia, Sarcopenia and Muscle, 2022
- Anti‐diabetic drugs and sarcopenia: emerging links, mechanistic insights, and clinical implicationsJournal of Cachexia, Sarcopenia and Muscle, 2021
- Sarcopenia and peripheral arterial disease: a systematic reviewJournal of Cachexia, Sarcopenia and Muscle, 2020
- Chronic heart failure with diabetes mellitus is characterized by a severe skeletal muscle pathologyJournal of Cachexia, Sarcopenia and Muscle, 2019
- Muscle fatigability in type 2 diabetesDiabetes/Metabolism Research and Reviews, 2016
- Accelerated atrophy of lower leg and foot muscles—a follow-up study of long-term diabetic polyneuropathy using magnetic resonance imaging (MRI)Diabetologia, 2009